(LION) Lionsgate Studios Corp. BCG Matrix Research |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
(LION) Lionsgate Studios Corp. Complete Analysis Pack
Unlock Strategic Clarity
This Lionsgate Studios Corp. BCG Matrix helps you quickly see how the company’s business areas may fit into Stars, Cash Cows, Question Marks, and Dogs for strategy and capital allocation. The content shown on this page is a real preview of the actual deliverable, so you can review the format and quality before buying. Purchase the full version to get the complete ready-to-use analysis.
Stars
John Wick franchise, 4 films, $1B+ worldwide
John Wick is one of Lionsgate Studios Corp.'s clearest Stars: 4 films have passed $1B worldwide, led by John Wick: Chapter 4 at $447.3M. Strong fan demand still supports sequels, spin-offs like Ballerina, premium marketing, and theatrical event runs. That mix of scale and momentum keeps the brand in a growth position, not a cash-cow one yet.
The Hunger Games franchise, 5 films, $3.3B+ worldwide
The Hunger Games franchise has already proven scale with 5 films and $3.3B+ in worldwide box office, making it one of Lionsgate Studios Corp.’s clearest Stars. The prequel pipeline keeps the brand active, with Sunrise on the Reaping set for 2026, so audience reach stays high into 2025 and beyond. It still needs strong marketing support, but its reach and legacy are exceptional.
Power universe, 4 scripted series by 2025
By 2025, the Power universe had 4 scripted series, showing Lionsgate Studios Corp.'s ability to keep a hit franchise alive across premium cable and streaming. The repeated spinoffs and returning seasons point to durable audience demand and low brand-friction for new launches. That makes it a clear Star: high visibility, proven reach, and room to keep growing.
The Strangers: Chapter 1 and Chapter 2, franchise relaunch
The Strangers: Chapter 1 and Chapter 2 give Lionsgate a low-cost horror relaunch with real sequel upside: Chapter 1 reportedly cost about $8 million and grossed about $35 million worldwide, a strong return for a genre built for follow-ons. Horror is still one of cinema’s most efficient sequel engines, and if Chapter 2 keeps audience demand alive, the franchise can shift from a question mark toward a star.
- Low budget, high franchise leverage
- Chapter 1: about $35M worldwide gross
- Strong fit for sequels and spin-offs
- Momentum can lift BCG placement
Lionsgate Television scripted commissions, ongoing 2025 slate
Lionsgate Television stays a Star in FY2025 because it keeps landing scripted commissions across streamers and networks, turning a broad slate into repeat orders and hit upside. That kind of volume model works best when new buyers keep coming in and series can scale fast, which is why this unit still looks like an expanding growth engine inside Lionsgate Studios Corp.
- Fresh commissions keep the slate expanding
- Repeat orders lift hit conversion odds
- Broad buyer mix lowers single-client risk
Lionsgate’s Star Franchises: Big Reach, Big Sequel Upside
John Wick, The Hunger Games, and Power remain Lionsgate Studios Corp. Stars: each has strong reach, repeat audience, and sequel or spin-off upside.
John Wick Chapter 4 grossed $447.3M worldwide, while The Hunger Games franchise crossed $3.3B across 5 films; Sunrise on the Reaping is set for 2026.
Power had 4 scripted series by 2025, and The Strangers: Chapter 1 cost about $8M and made about $35M worldwide, showing Star-like sequel leverage.
| Title | Key data |
|---|---|
| John Wick | $447.3M WW gross |
| The Hunger Games | $3.3B+ across 5 films |
What is included in the product
Detailed Word Document
Lionsgate Studios Corp. BCG Matrix maps film/TV units by growth and share to guide invest, hold, or divest decisions.
Editable Excel File
One-page Lionsgate Studios Corp. BCG Matrix that quickly spots winners, laggards, and capital needs.
Reference Sources
Lionsgate Studios Corp. reference sources validate key assumptions and give investors a fast, traceable basis for better decisions.
Cash Cows
20,000+ movie and TV titles in the library
Lionsgate Studios Corp.'s 20,000+ movie and TV titles make this a core Cash Cow: the library can be licensed again and again with little new production spend. Mature catalog rights tend to produce steady cash flow in a low-growth market, which helps fund new films and series. The scale of the library also supports bargaining power with streamers, TV buyers, and global syndication partners.
Twilight Saga, 5 films, $3.3B+ worldwide
The Twilight Saga’s 5 films have grossed $3.3B+ worldwide, making it a durable catalog seller long after release. Legacy fandom keeps demand alive across TV, streaming, and transactional windows.
That makes it a classic Cash Cow for Lionsgate Studios Corp.: mature, widely known, and still highly monetizable with low reinvestment needs.
Saw franchise, 10 films, $1B+ worldwide
The Saw franchise has 10 films and has passed $1 billion at the global box office, with Saw X (2023) taking about $112.6 million worldwide on a roughly $13 million budget. That kind of low-cost, steady sequel and catalog return is exactly why Lionsgate keeps it in the Cash Cows bucket. The brand is well mined, but it still throws off reliable value without needing blockbuster growth.
Catalog licensing to streaming, FAST, and TV
Lionsgate Studios Corp. turns one title into many sales: the same film or series can be licensed to TV, subscription streamers, and FAST channels in separate windows. Its library topped 20,000 titles in FY2025, so ad-supported and SVOD deals can keep generating steady, annuity-style cash flow.
- 20,000+ titles extend monetization windows
- FAST supports repeat ad revenue
- SVOD adds subscription licensing value
- One asset sells multiple times
Home entertainment and syndication from legacy titles
Lionsgate Studios Corp. turns legacy films and TV into a Cash Cow because back-catalog sales, licensing, and syndication need far less marketing than new releases. The company’s studio library spans 20,000+ titles, so returns come mainly from existing IP, not heavy fresh spend.
- Low promo spend
- High reuse of IP
- Stable licensing cash flow
That makes home entertainment and syndication a classic Cash Cow: mature assets, steady demand, and limited incremental investment.
Lionsgate’s IP Library Powers Steady Cash Flow
Lionsgate Studios Corp.’s Cash Cows are its 20,000+ title library and long-life franchises, which keep earning with little new spend. In FY2025, the library supported repeat licensing across TV, streaming, and FAST, turning one asset into multiple cash streams. Twilight has grossed $3.3B+ worldwide and Saw has topped $1B, showing how mature IP still drives steady returns.
| Asset | Key data |
|---|---|
| Library | 20,000+ titles, FY2025 |
| Twilight | 5 films, $3.3B+ worldwide |
| Saw | 10 films, $1B+ worldwide |
Get Your Copy
Lionsgate Studios Corp. Reference Sources
The Lionsgate Studios Corp. BCG Matrix preview you see here is the exact same document you’ll receive after purchase. No demo content, no placeholders—just the full, ready-to-use report. Once purchased, it’s instantly available for your business analysis, presentations, or strategic planning.
Dogs
Borderlands (2024), >$100M budget, about $33M worldwide
Borderlands (2024) is a clear Dog for Lionsgate Studios Corp. It cost over $100 million, but grossed only about $33 million worldwide, a steep loss versus budget. It also failed to build a breakout franchise, so the film ties up capital without showing a path to strong returns.
The Crow (2024), roughly $50M budget, under $25M worldwide
The Crow (2024) fits Dogs: a reboot with name recognition, but it did not turn that into scale, finishing at under $25 million worldwide against a roughly $50 million budget. That left a revenue gap too wide to support strong economics, even before marketing and distribution costs. In Lionsgate Studios Corp.'s portfolio terms, it shows weak share in a tough market and poor return on capital.
The Killer's Game (2024), sub-$10M worldwide
The Killer's Game (2024) grossed about $5.8 million worldwide, far below a wide-release hit. It drew no broad theatrical audience and had no franchise pull to drive repeat demand or sequel value. In Lionsgate Studios Corp.'s BCG Matrix, that puts it in Dog territory: low growth, low share, and weak strategic lift.
White Bird: A Wonder Story (2024), under $20M worldwide
White Bird: A Wonder Story (2024) stayed under $20 million worldwide, so it never reached meaningful box office scale for Lionsgate Studios Corp. With a weak theatrical footprint and no clear sequel engine, it fits the low-growth, low-share corner of the BCG Matrix. In BCG terms, it is a Dog: limited cash generation, limited franchise reuse.
Worldwide gross: under $20 million
Weak scale, low repeatability
Not a franchise builder
Low-growth, low-share asset
The Ministry of Ungentlemanly Warfare (2024), about $27M worldwide
The Ministry of Ungentlemanly Warfare (2024) is a clear Dog for Lionsgate Studios Corp: it grossed about $27M worldwide and never showed breakout demand. With a reported production budget near $60M, the film likely fell well short of full theatrical upside, and it had no sequel or franchise engine to extend value.
- Worldwide box office: about $27M
- Reported budget: about $60M
- No sequel momentum or franchise lift
- Best fit: low-growth Dog
Lionsgate’s 2024 “Dogs” Burned Cash and Delivered Little Return
Dogs in Lionsgate Studios Corp.'s BCG mix are the 2024 releases that burned cash and showed no franchise lift. Borderlands grossed about $33M worldwide against a budget over $100M, The Crow finished under $25M worldwide on a roughly $50M budget, and The Killer's Game took only about $5.8M worldwide.
White Bird: A Wonder Story stayed under $20M worldwide, and The Ministry of Ungentlemanly Warfare reached about $27M worldwide on a near-$60M budget. These titles sit in low-share, low-growth slots with weak return on capital.
| Title | WW Gross | Budget | BCG |
|---|---|---|---|
| Borderlands | $33M | >$100M | Dog |
| The Crow | <$25M | ~$50M | Dog |
| The Killer's Game | $5.8M | n/a | Dog |
| White Bird | <$20M | n/a | Dog |
| Ministry | $27M | ~$60M | Dog |
Question Marks
The Hunger Games: Sunrise on the Reaping, 2026
The Hunger Games: Sunrise on the Reaping is a Question Mark for Lionsgate Studios Corp. It has strong brand pull, with The Hunger Games films taking in about $3.3 billion worldwide, but this prequel has no box-office record yet. After The Ballad of Songbirds & Snakes grossed $338.9 million worldwide in 2023, it could become a major tentpole if demand carries over. Until then, it remains a high-upside bet for the November 2026 launch.
Michael, 2026
Michael is a high-profile biopic with huge built-in curiosity, helped by Michael Jackson’s estimated 400 million records sold worldwide. It could travel globally if reviews land well, but biopics are hit-or-miss at the box office. For Lionsgate Studios Corp., that mix of reach and uncertainty makes Michael a classic Question Mark.
The Housemaid, 2025/2026
The Housemaid has a built-in audience: Freida McFadden’s novel hit No. 1 on The New York Times bestseller list. But it has no film box-office proof yet, so its BCG share remains untested.
Upside depends on casting, marketing, and release timing, because thriller demand can swing fast. If Lionsgate lands the right star and window, this could move from a Question Mark toward a stronger share.
The Long Walk, 2025
Stephen King IP gives The Long Walk built-in name recognition, but it is still unproven as a mass-market franchise. Since its commercial ceiling depends on how well the 2025 adaptation lands with viewers, it fits Question Mark in Lionsgate Studios Corp. BCG terms.
- Known IP, limited franchise proof
- Box office depends on adaptation quality
- Upside if audience response is strong
Now You See Me: Now You Don't, 2025
Now You See Me: Now You Don’t, 2025 sits as a Question Mark in Lionsgate Studios Corp.'s BCG Matrix: it extends a known brand, but it still has to prove it can pull its own box office weight. The first two films grossed about $686.2 million worldwide combined, with $351.7 million in 2013 and $334.5 million in 2016, so the franchise has a real base. Still, only 2025 audience response will show whether this sequel becomes a bigger engine or stays a cautious bet.
- Known brand, unproven sequel draw.
- Prior films earned $686.2 million worldwide.
- Box office will decide its franchise value.
Lionsgate’s High-IP Bets: Big Names, Big Upside, Still Unproven
Lionsgate Studios Corp.’s Question Marks are mostly high-IP bets with no clear box-office proof yet. The Hunger Games: Sunrise on the Reaping, Michael, The Housemaid, The Long Walk, and Now You See Me: Now You Don’t each have brand pull, but their 2025–2026 upside still depends on release execution and audience demand.
| Title | Proof | Status |
|---|---|---|
| Sunrise on the Reaping | $3.3B franchise | Question Mark |
| Michael | 400M records | Question Mark |
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.